Central Nervous System Stimulants & Patient Characteristics and Utilization Read more about Central nervous system stimulants
Informed Original FDA Labeling: Paxlovid Boxed Warning on Drug Interactions Read more about Informed Original FDA Labeling: Paxlovid Boxed Warning on Drug Interactions
An Assessment of the Sentinel System (2022 to 2024) Read more about An Assessment of the Sentinel System (2022 to 2024)
Developing a Prediction Model to Estimate the Magnitude of Exposure Read more about Developing a Prediction Model to Estimate the Magnitude of Exposure
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis Read more about Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis
Capturing Pediatric Health and Medication Use in a US National Health Data Network Read more about Capturing Pediatric Health and Medication Use in a US National Health Data Network
Ocular Hypertension Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Read more about Ocular Hypertension Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Nasal Septal Perforation Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Read more about Nasal Septal Perforation Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"